USD10
XFOR Shares
About X4 PharmaceuticalsX4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
USD10
XFOR Shares
About X4 PharmaceuticalsX4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$385.50M
OPEN PRICE
$4.23
LOW (1Y)
$1.35
HIGH (1Y)
$6.96
LOW (24H)
$4.17
HIGH (24H)
$4.44
VOLUME (24H)
$206.10K
53.85%
Price history
Time | Price | Change |
|---|---|---|
Today | $4.23 | |
1 Day | $4.24 | 0.00% |
1 Week | $4.04 | |
1 Month | $3.59 | |
1 Year | $6.36 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
